Drug and Alcohol Review

Papers
(The H4-Index of Drug and Alcohol Review is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Alcohol consumption, harms and policy developments in sub‐Saharan Africa: The case for stronger national and regional responses67
Purchasing, consumption, demographic and socioeconomic variables associated with shifts in alcohol consumption during the COVID‐19 pandemic67
Changes in alcohol use during theCOVID‐19 pandemic in Europe: A meta‐analysis of observational studies66
How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis42
A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry42
Why do women consume alcohol during pregnancy or while breastfeeding?40
Overdose deaths and the COVID‐19 pandemic in British Columbia, Canada40
Characterising the patterns of and factors associated with increased alcohol consumption since COVID‐19 in a UK sample38
Alcohol control policies in Former Soviet Union countries: A narrative review of three decades of policy changes and their apparent effects35
Online alcohol delivery is associated with heavier drinking during the first New Zealand COVID‐19 pandemic restrictions32
Advancing the science on cannabis concentrates and behavioural health31
Implications of addiction diagnosis and addiction beliefs for public stigma: A cross‐national experimental study30
Opioid agonist treatment and patient outcomes during the COVID‐19 pandemic in south east Sydney, Australia26
Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross‐sectional survey25
COVID‐19 vaccination among people who inject drugs: Leaving no one behind25
Young‐adult compared to adolescent onset of regular cannabis use: A 20‐year prospective cohort study of later consequences24
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine24
The alcohol advertising ban in Norway: Effects on recorded alcohol sales23
The influence of child maltreatment on substance or alcohol use in 30‐year‐old adults: A birth cohort study23
Dialectical behaviour therapy skills training for individuals with substance use disorder: A systematic review23
Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case series22
The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification22
0.040894031524658